Let's Win Pancreatic Cancer 💜

Pancreatic cancer is most often caught late. On the latest PancChat, Dr. Ray Wadlow breaks down who should be screened, what genetic mutations to know about, and how the @PrecedeStudy is working to change early detection at a global scale. Listen: youtu.be/LlaPFCDYz28

Also very distinct response in pancreas cancer for Q61 Ras Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS Q61 Mutations to Assess Therapeutic Response aacrjournals.org/clincancerres/…

The draft guideline recommendations for "Integration of Patient-Reported Outcomes in the Routine Care of Adults Undergoing Systemic Treatment for Cancer" are now available. Help us refine these standards of care. Submit your feedback to us by July 22: bit.ly/4wtFE4Q

The importance of critical review of scientific literature, featuring a certain Jim Allison, who plays harmonica for The Checkpoints. cancerletter.com/news-analysis/…

🎗️ Advancing KRAS Research: @break_cancer and the @lustgartenfdn have launched a $16M TeamLab initiative to investigate resistance, biomarkers, and combination strategies in #pancreaticcancer to improve patient outcomes. 🔗 ascopost.com/news/july-2026…

As European, this is the news I wanted to read since weeks #KRAS #PancreaticCancer @KRASKickers

Nationwide 🇳🇱 cohort on #Pain 😰prevalence in #PancreaticCancer: >50% in pts with advanced pancreatic cancer (LAPC & M1) 👉Pain remains a key concern that can be positively influenced by chemotherapy. 🤝These findings emphasize the need for routine #pain assessment and individualized symptom management from diagnosis onward. journals.lww.com/pain/fulltext/…

Join us on Thursday!

With a stage IV diagnosis at 33, Matthew Rosenblum thought his life was over. But he’s a long-term survivor and has everything he never thought possible. bit.ly/4f0atXD

Daraxonrasib wasn’t the only research news to come out at ASCO 2026. Learn about other new drugs and tests for pancreatic cancer. bit.ly/3RhSynD

The Let’s Win Patient Advisory Board looks back at changes in the last 10 years for pancreatic cancer treatment, screening, and patient care. bit.ly/4fhJUi5

Join @drallysonocean for a @letswinpc webinar on 7/8 to learn more about daraxonrasib and other new & upcoming #PancreaticCancer treatments, including those in #ClinicalTrials. Register here: bit.ly/4xY0vig

Thrilled 🤩 to join this 🔋Powerhouse session at #ESMOGI2026. Incredible to witness so many advances in pancreatic cancer presented on one stage and to share it with leaders including Brian Wolpin, Nilo Azad, Eric Van Cutsem and @MacarullaTeresa The era of K/RAS inhibitors, rational combinations and biomarker-driven therapeutics is here. #daraxonrasib #zoldonrasib Unprecedented response rates in this disease ever! We keep learning from the positive and negative work. Search and REsearch! I really appreciate the team so dedicated to learn the science from the #GLEAM trial #CLDN18 #zolbetuximab We’re finally moving the field forward. The future of pancreatic cancer has never looked brighter 💡 #PancreaticCancer #KRAS #RAS #TeamScience @MSKCancerCenter @MSK_DeptOfMed @CpcrMsk @PanCAN @letswinpc @Pankind_Aus @OncoAlert @OncBrothers @oncodaily @OncoDailyGI @NatPancFdn

POV: Your Apple Watch thinks something is wrong… …but you’re just about to present at #ESMOGI26. 😄⌚️💕💗💜 Discussing the Phase II GLEAM study and joining conversations on the future of pancreatic cancer. Worth every heartbeat. 💗 #PancreaticCancer #GIOncology #KRAS #ClinicalTrials @myESMO @CpcrMsk @MSKCancerCenter @MSK_DeptOfMed @oncodaily @OncoDailyGI

@CentralParkWMD @PanCAN @Pankind_Aus @OncBrothers @oncodaily @OncoDailyGI If you shake your protein drink hard enough to blend it, your Apple Watch will give you credit for washing your hands. 🤣

When Roberta L. was diagnosed with #pancreaticcancer in 2002, she was given months to live. Twenty-four years later, she's sharing her remarkable story of resilience. 💜 In this episode of PancChat, Roberta joins host @AlisynCamerota to discuss her stage III diagnosis, the role of clinical trials, the lifestyle changes she embraced and how she navigates survivor's guilt. She also shares why she's never made a bucket list — and why she skydives every April instead. Listen to the latest episode at 🔗 bit.ly/426sqy5. PancChat is a collaboration between @LetsWinPC and PanCAN, sponsored by @RevMedicines.

New pancreatic cancer treatment for advanced stages is heading to approval. Join us + Nuestras Voces Adelante Network for a webinar on 7/8 at 2pm ET. Dr. Gulam Manji and @DrAllysonOcean break down what's available now and what's on the horizon. 💜 bit.ly/3Re1omf

Egads. Not better and higher mortality. Hmmmm.

She also shares why she's never made a bucket list — and why she jumps out of a plane every April instead. Listen to this conversation about hope, advocacy, and finding your "why" youtu.be/Id-G_M0KPjk PancChat is a collab between Let's Win and @PanCAN.

Roberta Luna is a 24-year pancreatic cancer survivor. In this episode, Roberta talks about navigating a stage three diagnosis, the role of clinical trials, the diet and lifestyle changes she credits with her health, and the survivor's guilt that comes with outliving a prognosis.